Use access key #2 to skip to page content.
$8.52 -0.48 (-5.33%)
10/7/2008 4:03 PM

Mylan Laboratories, Inc. (MYL)

CAPS Rating:
****

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

View All Commentary (MYL)

Recs

3

Avatar DouglasRich (< 20) Submitted: 1/29/08 9:30 AM : Underperform Start Price: $14.68 MYL Score: 15.47

Mylan is known for making good quality, reliable generic pharmaceutical products, but I think their primary drawback is they haven't found a way to outcompete the generic market. In the pharmacy, cheaper generics are preferred to Mylan's oftentimes more expensive products. Teva and Dr. Reddy are two companies, even though their tablets crumble to the touch, will always beat Mylan out of the inventory at CVS or Walgreens.

Report this Post Replies: 0 | Reply

Featured Broker Partners